![Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes | Nature Communications Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fncomms7748/MediaObjects/41467_2015_Article_BFncomms7748_Fig1_HTML.jpg)
Reduced Tyk2 gene expression in β-cells due to natural mutation determines susceptibility to virus-induced diabetes | Nature Communications
![TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases | Immunotherapy TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2021-0096/asset/images/medium/figure1.gif)
TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases | Immunotherapy
![Overview of cytokine receptors and associated Janus kinases (JAKs).... | Download Scientific Diagram Overview of cytokine receptors and associated Janus kinases (JAKs).... | Download Scientific Diagram](https://www.researchgate.net/publication/236039248/figure/fig1/AS:667186473488384@1536081059202/Overview-of-cytokine-receptors-and-associated-Janus-kinases-JAKs-TYK2-is-associated.png)
Overview of cytokine receptors and associated Janus kinases (JAKs).... | Download Scientific Diagram
Identification of imidazo[1,2-b]pyridazine TYK2 pseudokinase ligands as potent and selective allosteric inhibitors of TYK2 signalling - MedChemComm (RSC Publishing)
![Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences | Scientific Reports Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-020-65762-y/MediaObjects/41598_2020_65762_Fig1_HTML.png)
Demonstration of In Vitro to In Vivo Translation of a TYK2 Inhibitor That Shows Cross Species Potency Differences | Scientific Reports
![TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors - Jo - 2022 - International Journal of Dermatology - Wiley Online Library TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors - Jo - 2022 - International Journal of Dermatology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/16695c54-be5c-45ae-ae81-df8e78a60477/ijd15605-fig-0001-m.jpg)
TYK 2 inhibitors for the treatment of dermatologic conditions: the evolution of JAK inhibitors - Jo - 2022 - International Journal of Dermatology - Wiley Online Library
![BMS-986165 is a Highly Selective and Orally Active TYK2 Inhibitor for Autoimmune Diseases Treatment - Immune System Research BMS-986165 is a Highly Selective and Orally Active TYK2 Inhibitor for Autoimmune Diseases Treatment - Immune System Research](https://www.immune-system-research.com/wp-content/uploads/2019/08/BMS-986165-is-a-Highly-Selective-and-Orally-Active-TYK2-Inhibitor-for-Autoimmune-Diseases-Treatment-2019-08-20.jpg)
BMS-986165 is a Highly Selective and Orally Active TYK2 Inhibitor for Autoimmune Diseases Treatment - Immune System Research
![A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.8b01397/asset/images/large/jm-2018-01397g_0002.jpeg)
A Dual Inhibition, a Better Solution: Development of a JAK1/TYK2 inhibitor | Journal of Medicinal Chemistry
![TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases | Immunotherapy TYK2 as a therapeutic target in the treatment of autoimmune and inflammatory diseases | Immunotherapy](https://www.futuremedicine.com/cms/10.2217/imt-2021-0096/asset/images/medium/figure3.gif)